Staffan Encrantz - Nov 24, 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz
Stock symbol
SGHT
Transactions as of
Nov 24, 2023
Transactions value $
$1,760,511
Form type
4
Date filed
11/28/2023, 08:32 PM
Previous filing
Nov 22, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Purchase $67.4K +21.9K +6.31% $3.09 368K Nov 24, 2023 Direct F1
transaction SGHT Common Stock Purchase $816K +246K +66.91% $3.31 614K Nov 27, 2023 Direct F2
transaction SGHT Common Stock Purchase $877K +254K +41.28% $3.46 868K Nov 28, 2023 Direct F3, F4
holding SGHT Common Stock 1.18M Nov 24, 2023 See footnote F5
holding SGHT Common Stock 4.02M Nov 24, 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price at which these shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased. The shares were purchased in multiple transactions at prices ranging from $2.96 to $3.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Reflects the weighted average price at which these shares of Common Stock were purchased. The shares were purchased in multiple transactions at prices ranging from $3.035 to $3.355, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 Reflects the weighted average price at which these shares of Common Stock were purchased. The shares were purchased in multiple transactions at prices ranging from $3.275 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 Includes 15,094 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2023 under the Issuer's Non-Employee Director Compensation Program, which are subject to vesting as previously reported. Each RSU represents a contingent right to receive one share of Common Stock.
F5 These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
F6 These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.